Hemenway Trust CO LLC Vertex Pharmaceuticals Inc Transaction History

Hemenway Trust CO LLC

$1.19 Billion
Q3 2024

A detailed history of Hemenway Trust CO LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hemenway Trust CO LLC holds 40,119 shares of VRTX stock, worth $18.1 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares

40,119

Previous 28,437 41.08%

Holding current value

$18.1 Million

Previous $13.3 Million 39.99%

% of portfolio

1.56%

Previous 1.19%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$460.0 - $505.78 $5.37 Million - $5.91 Million	11,682 Added 41.08%	40,119 $18.7 Million
Q2 2024 Aug 05, 2024	BUY	$392.81 - $485.53 $5.07 Million - $6.27 Million	12,919 Added 83.25%	28,437 $13.3 Million
Q1 2024 May 03, 2024	BUY	$407.69 - $446.08 $4.42 Million - $4.83 Million	10,835 Added 231.37%	15,518 $6.49 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $314,531 - $376,593	917 Added 24.35%	4,683 $1.91 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $13,527 - $14,498	40 Added 1.07%	3,766 $1.31 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $58,167 - $65,103	185 Added 5.22%	3,726 $1.31 Million
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $1,416 - $1,615	-5 Reduced 0.14%	3,541 $1.12 Million
Q4 2022 Feb 08, 2023	BUY	$285.76 - $321.48 $35,720 - $40,185	125 Added 3.65%	3,546 $1.02 Million
Q3 2022 Nov 08, 2022	BUY	$273.83 - $305.53 $243,708 - $271,921	890 Added 35.16%	3,421 $991,000
Q2 2022 Jul 19, 2022	BUY	$234.96 - $292.55 $260,805 - $324,730	1,110 Added 78.11%	2,531 $713,000
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $257,755 - $288,448	1,421 New	1,421 $258,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemenway Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hemenway Trust CO LLC with notifications on news.

Account

Hemenway Trust CO LLC Vertex Pharmaceuticals Inc Transaction History